Atovaquon/Proguanilhydrochlorid Al

Atovaquone/Proguanil Hydrochloride Al is a combination medication used to prevent and treat malaria. This oral medication is effective in managing malaria caused by Plasmodium falciparum.

Atovaquone/Proguanil Hydrochloride Al is primarily used for the prevention and treatment of malaria. It is effective against Plasmodium falciparum, a common cause of malaria. This medication is often prescribed for travelers to areas where malaria is prevalent. It works by interfering with the growth of the malaria parasite in the red blood cells.

Common effects of Atovaquone/Proguanil Hydrochloride Al may include nausea, vomiting, diarrhea, and headache. Some users may experience abdominal pain or loss of appetite. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Atovaquone/Proguanil Hydrochloride Al should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment. This medication should be stored at room temperature and kept out of reach of children.

Atovaquone/Proguanil Hydrochloride Al may interact with certain medications, including antacids, metoclopramide, and cholestyramine. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while taking this medication.